asterisk2a + r&d + stp   1

Cancer patients could be disadvantaged by Brexit, say experts | Society | The Guardian
In an editorial published on Friday in the ecancermedicalscience journal, six doctors, representing cancer physicians, patient advocacy groups and genomics researchers, said the UK government must be prepared to fill in the gaps in law, regulation and resource allocation that would open up after Brexit. [...] Brexit would mean that the EU directive no longer applied in the UK, which is of concern to the manufacturers of devices and tests unless the EU and the UK share regulatory frameworks in future to allow ready import and export of devices/tests.”
Brexit  NHS  Austerity  STP  Cancer  R&D  rationing  medical  advances  science  STEM  EEA  regulation 
february 2017 by asterisk2a

Copy this bookmark:



description:


tags: